Companies / Vector Science & Therapeutics

Medical device company profile

Vector Science & Therapeutics

Developer of localized therapeutic delivery platforms, alongside a peptide manufacturing and supply business.

Manufacturer / DeveloperGeneral Medical & Patient CareOrthopedics & MusculoskeletalInfusion & InjectionDevelopment-stage

HeadquartersNot established

FoundedNot confirmed

Commercial statusIn developmentDelivery-device platforms are in development; peptide production is a separate business activity.

EmployeesNot confirmed

Estimated revenueNot confirmed

Official websitevectorscience.co ↗

Company overview

Vector Science & Therapeutics develops devices and platforms for localized therapeutic delivery. Its programs include VectorMist for atomized delivery and a transdermal platform for musculoskeletal applications. The company also operates a distinct peptide business through manufacturing partnerships.

The delivery-device programs are in development. VectorMist is described as pre-launch, while the Valor program explores electrically assisted and wearable approaches to transdermal peptide delivery. The company’s peptide production activity does not establish commercial availability or authorization of these devices.

^{[1][2][3][4][5][6]}

Leadership

4 people

Bill JacksonChief Executive Officer ^[9]

Russell StarrPresident ^[9]

Barry HixChief Commercial Officer ^[9]

Tom BachinskiChief Technology Officer ^[9]

Products & regulatory status How does MedTechIndex get this information?

Summary

VectorMist and Valor are development programs for therapeutic delivery. Their proposed clinical uses and performance remain distinct from the company’s peptide manufacturing activity. ^[8][10]

Regulatory snapshot How to read this snapshot

U.S. FDA

0
510(k) clearances: 0
De Novo grants: 0
PMA approvals: 0
Recall events

Latest recorded source review: 2026-10-30.

Scope: selected product families.

Commercial portfolio snapshot

Therapeutic delivery platforms are in development.

Commercial development

Localized therapeutic delivery platform

VectorMist ↗

Pre-launch platform for localized, atomized therapeutic delivery, associated with the LASSO laparoscopic delivery program. ^[8][7]

Pre-commercial development; specifications and indications remain limited in public materials.

Therapeutic delivery device program

Valor transdermal platform ↗

Development program combining biomechanical and electrically assisted delivery approaches for transdermal peptide administration. ^[10]

Development-stage program for sports and musculoskeletal applications.

10 Cited Sources

Accessed 10/30/2026

Last substantive review: 10/30/2026

[1] FDA 510(k) database — research search ↗U.S. Food and Drug Administration · regulatory databaseFDA database search page; not an individual device record.

[2] FDA enforcement reports database — research search ↗U.S. Food and Drug Administration · regulatory databaseFDA database search page; not an individual device record.

[3] FDA PMA database — research search ↗U.S. Food and Drug Administration · regulatory databaseFDA database search page; not an individual device record.

[4] FDA medical-device recall database — research search ↗U.S. Food and Drug Administration · regulatory databaseFDA database search page; not an individual device record.

[5] Company and business activities ↗Vector Science & Therapeutics · company website

[6] Device-development approach ↗Vector Science & Therapeutics · company website

[7] Company announcements ↗Vector Science & Therapeutics · company website

[8] VectorMist platform ↗Vector Science & Therapeutics · company website

[9] Leadership ↗Vector Science & Therapeutics · company website

[10] Valor transdermal delivery program ↗Vector Science & Therapeutics · company website